{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:33:47Z","timestamp":1773279227093,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.neuropharm.2009.11.018","type":"journal-article","created":{"date-parts":[[2009,12,12]],"date-time":"2009-12-12T09:17:59Z","timestamp":1260609479000},"page":"585-592","source":"Crossref","is-referenced-by-count":66,"title":["Functional and biochemical evidence indicating beneficial effect of Melatonin and Nicotinamide alone and in combination in experimental diabetic neuropathy"],"prefix":"10.1016","volume":"58","author":[{"given":"Geeta","family":"Negi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashutosh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravinder K.","family":"Kaundal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyam S.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2009.11.018_bib1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1095-6433(03)00114-4","article-title":"Oxidative stress in streptozotocin-induced diabetic rats: effects of garlic oil and melatonin","volume":"135","author":"Anwar","year":"2003","journal-title":"Comp. Biochem. Physiol. A: Mol. Integr. Physiol."},{"key":"10.1016\/j.neuropharm.2009.11.018_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejphar.2008.08.003","article-title":"Amelioration of neurological and biochemical deficits by peroxynitrite decomposition catalysts in experimental diabetic neuropathy","volume":"596","author":"Arora","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.11.018_bib3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejphar.2007.09.006","article-title":"Melatonin reduces formalin-induced nociception and tactile allodynia in diabetic rats","volume":"577","author":"Arreola-Espino","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.11.018_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/sj.bjp.0704216","article-title":"Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve","volume":"134","author":"Coppey","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.11.018_bib5","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.2337\/diabetes.50.8.1927","article-title":"Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve","volume":"50","author":"Coppey","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2009.11.018_bib6","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1600-079X.2004.00188.x","article-title":"Melatonin-induced modulation of glucose metabolism in primary cultures of rabbit kidney-cortex tubules","volume":"38","author":"Derlacz","year":"2005","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.neuropharm.2009.11.018_bib7","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1172\/JCI18127","article-title":"Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells","volume":"112","author":"Du","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2009.11.018_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.acthis.2006.03.005","article-title":"Effects of melatonin on streptozotocin-induced diabetic liver injury in rats","volume":"108","author":"Guven","year":"2006","journal-title":"Acta Histochem."},{"key":"10.1016\/j.neuropharm.2009.11.018_bib9","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1007\/s00018-002-8527-2","article-title":"The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders","volume":"59","author":"Hassa","year":"2002","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2009.11.018_bib10","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.2337\/diabetes.51.9.2817","article-title":"Nitrosative stress, uric acid, and peripheral nerve function in early type1 diabetes","volume":"51","author":"Hoeldtke","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2009.11.018_bib11","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.2337\/db06-0067","article-title":"Poly(ADP-Ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy","volume":"55","author":"Ilnytska","year":"2006","journal-title":"Diabetes"},{"issue":"Pt 3","key":"10.1016\/j.neuropharm.2009.11.018_bib12","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1042\/0264-6021:3460641","article-title":"Evidence for regulation of NF-kappaB by poly(ADP-ribose) polymerase","volume":"346","author":"Kameoka","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2009.11.018_bib13","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00204-005-0055-z","article-title":"Depression of glucose levels and partial restoration of pancreatic beta-cell damage by melatonin in streptozotocin-induced diabetic rats","volume":"80","author":"Kanter","year":"2006","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.neuropharm.2009.11.018_bib14","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.lfs.2006.12.036","article-title":"Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy","volume":"80","author":"Kumar","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2009.11.018_bib15","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.2337\/diabetes.54.5.1514","article-title":"Low-dose poly(ADP-ribose) polymerase inhibitor-containing combination therapies reverse early peripheral diabetic neuropathy","volume":"54","author":"Li","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2009.11.018_bib16","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1073\/pnas.84.5.1286","article-title":"Poly(ADP-ribose) may signal changing metabolic conditions to the chromatin of mammalian cells","volume":"84","author":"Loetscher","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2009.11.018_bib17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/1570161054368571","article-title":"Role of nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic vascular dysfunction","volume":"3","author":"Mabley","year":"2005","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.11.018_bib18","doi-asserted-by":"crossref","unstructured":"Negi, G., Kumar, A., Sharma, S.S. Concurrent targeting of nitrosative stress-PARP pathway corrects functional, behavioral and biochemical deficits in experimental diabetic neuropathy. Biochem. Biophys. Res. Commun., in press. doi:10.1016\/j.bbrc.2009.11.010.","DOI":"10.1016\/j.bbrc.2009.11.010"},{"key":"10.1016\/j.neuropharm.2009.11.018_bib19","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/0003-2697(69)90025-6","article-title":"A simple ultramicro method for determination of pyridine nucleotides in tissue","volume":"27","author":"Nisselbaum","year":"1969","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuropharm.2009.11.018_bib20","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.freeradbiomed.2006.06.009","article-title":"Peroxynitrite and cardiomyocyte cell death: an evolving story. A commentary on \u201cPeroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo\u201d","volume":"41","author":"Obrosova","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2009.11.018_bib21","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.2337\/diabetes.54.12.3435","article-title":"Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited","volume":"54","author":"Obrosova","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2009.11.018_bib22","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2337\/diabetes.53.3.711","article-title":"Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy","volume":"53","author":"Obrosova","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2009.11.018_bib23","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.freeradbiomed.2007.09.013","article-title":"PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy","volume":"44","author":"Obrosova","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2009.11.018_bib24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuropharm.2009.11.018_bib25","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejphar.2007.01.070","article-title":"PARP inhibition reduces acute colonic inflammation in rats","volume":"563","author":"S\u00e1nchez-Fidalgo","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.11.018_bib26","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.lfs.2006.02.033","article-title":"Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy","volume":"79","author":"Sayyed","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2009.11.018_bib27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2337\/diabetes.52.1.165","article-title":"Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy","volume":"52","author":"Schmeichel","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2009.11.018_bib28","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1080\/10715760902801509","article-title":"Neuroprotective potential of combination of resveratrol and 4-amino1,8 naphthalimide in experimental diabetic neuropathy: focus on functional, sensorimotor and biochemical changes","volume":"43","author":"Sharma","year":"2009","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.neuropharm.2009.11.018_bib29","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.lfs.2007.11.031","article-title":"Protective effects of 4-amino1,8-napthalimide, a poly (ADP-ribose) polymerase inhibitor in experimental diabetic neuropathy","volume":"82","author":"Sharma","year":"2008","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2009.11.018_bib30","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1210\/er.2004-0028","article-title":"Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options","volume":"26","author":"Srivastava","year":"2005","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.neuropharm.2009.11.018_bib31","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1124\/jpet.106.109702","article-title":"Nicotinamide reverses neurological and neurovascular deficits in streptozotocin diabetic rats","volume":"320","author":"Stevens","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2009.11.018_bib36","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejphar.2007.05.018","article-title":"Melatonin attenuates metabolic disorders due to streptozotocin induced diabetes in rats","volume":"569","author":"Sudnikosh","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.11.018_bib32","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2174\/138161208784139774","article-title":"Role of advanced glycation end products in diabetic neuropathy","volume":"14","author":"Sugimoto","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuropharm.2009.11.018_bib33","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2174\/138945008783431754","article-title":"The antioxidant response as a drug target in diabetic neuropathy","volume":"9","author":"Vincent","year":"2008","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.neuropharm.2009.11.018_bib34","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1471-4159.2007.05050.x","article-title":"Correction of protein kinase C activity and macrophage migration in peripheral nerve by pioglitazone, peroxisome proliferator activated-gamma-ligand, in insulin-deficient diabetic rats","volume":"104","author":"Yamagishi","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2009.11.018_bib35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3940(02)01005-4","article-title":"The effects of nicotinamide on energy metabolism following transient focal cerebral ischemia in Wistar rats","volume":"333","author":"Yang","year":"2002","journal-title":"Neurosci. Lett."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390809003669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390809003669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T05:11:37Z","timestamp":1710738697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390809003669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0028390809003669"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2009.11.018","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}